TAMMIE MICHAEL: Open Payments
NPI 1053708693 · GALVESTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$669 in 7 payments from 7 companies in 2025. Trend: 2023 $344 · 2024 $586 · 2025 $669
Food & beverage: $669
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 1 | $140 |
| Teva Pharmaceuticals USA, Inc. | 1 | $133 |
| ABBVIE INC. | 1 | $111 |
| Axsome Therapeutics, Inc. | 1 | $98 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $67 |
| Lundbeck LLC | 1 | $60 |
| Otsuka America Pharmaceutical, Inc. | 1 | $60 |
Products named: REXULTI, REZDIFFRA, VRAYLAR, Auvelity.
Industry payments across TX — which companies pay providers there.
